| Trial ID: | L2570 |
| Source ID: | NCT01276912
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
Study TO Prevent Diabetes With Short-term Insulin Glargine Only
|
| Acronym: |
STOP-GO
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Pre-diabetes
|
| Interventions: |
DRUG: Insulin glargine|BEHAVIORAL: Lifestyle counseling
|
| Outcome Measures: |
Primary: HbA1c >= 6.5%, Two years | Secondary: FPG >= 7.0 for two times in a month., Two years|HbA1c >= 7.0%, Two years
|
| Sponsor/Collaborators: |
Sponsor: Beijing Tongren Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2420
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2011-01
|
| Completion Date: |
2013-12
|
| Results First Posted: |
|
| Last Update Posted: |
2011-01-14
|
| Locations: |
Beijing Tongren Hospital, Beijing, 100730, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01276912
|
